Literature DB >> 17403172

Quality of life of end-stage renal disease patients and study on the implementation of nocturnal home hemodialysis in Greece.

Kallirroi Stavrianou1, Nicolas Pallikarakis.   

Abstract

The aim of this study was to measure the overall health-related quality of life of patients receiving hemodialysis in Greece and to assess willingness, motivation, and concerns about participating in a nocturnal home hemodialysis program. This review measured successfully the quality of life of 146 end-stage renal disease (ESRD) patients undergoing hemodialysis in 10 hemodialysis centers all over Greece and studied the factors that affect their choice to adopt a specific treatment. Physical and mental health status and health-related quality of life, measured by the Kidney Disease Quality of Life Short Form accompanied by the demographic data gathered, provide information that can help to improve ESRD patient care in Greece. A comparison with the Greek general population identifies lower physical functioning scores for the ESRD patients, while the mental functioning scores are comparable with those of the Greek general population. Moreover, it is important to notice the willingness expressed by half of the patients to participate in a potential program of nocturnal home hemodialysis.

Entities:  

Mesh:

Year:  2007        PMID: 17403172     DOI: 10.1111/j.1542-4758.2007.00170.x

Source DB:  PubMed          Journal:  Hemodial Int        ISSN: 1492-7535            Impact factor:   1.812


  2 in total

1.  The Association between Psychosocial and Age-Related Factors with Adherence to Immunosuppressive Therapies after Renal Transplantation.

Authors:  Justyna Zachciał; Izabella Uchmanowicz; Michał Czapla; Magdalena Krajewska; Mirosław Banasik
Journal:  J Clin Med       Date:  2022-04-24       Impact factor: 4.964

2.  Measuring health related quality of life (hrqol) in renal transplant patients: psychometric properties and cross-cultural adaptation of kidney transplant questionnaire (ktq-25) in persian.

Authors:  Ali Tayyebi; Afsaneh Raiesifar; Soheil Najafi Mehri; Abbas Ebadi; Behzad Einolahi; Shadi Pashandi
Journal:  Nephrourol Mon       Date:  2012-09-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.